MARKET

QNCX

QNCX

Quince
NASDAQ
4.010
+0.410
+11.39%
After Hours: 3.990 -0.02 -0.50% 19:57 12/05 EST
OPEN
3.680
PREV CLOSE
3.600
HIGH
4.300
LOW
3.650
VOLUME
1.80M
TURNOVER
--
52 WEEK HIGH
4.300
52 WEEK LOW
0.7203
MARKET CAP
223.28M
P/E (TTM)
-3.2880
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 3d ago
Monday Sector Laggards: Biotechnology, Electronic Equipment & Products
NASDAQ · 4d ago
Weekly Report: what happened at QNCX last week (1124-1128)?
Weekly Report · 4d ago
Catalyst Watch: Holiday shopping data, Amazon event, and Salesforce earnings
Seeking Alpha · 11/28 18:30
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 11/26 17:05
Quince Therapeutics to Present at Piper Sandler Healthcare Conference
Reuters · 11/24 13:00
Weekly Report: what happened at QNCX last week (1117-1121)?
Weekly Report · 11/24 09:45
Weekly Report: what happened at QNCX last week (1110-1114)?
Weekly Report · 11/17 09:45
More
About QNCX
Quince Therapeutics, Inc. is a late-stage biotechnology company. The Company is engaged in unlocking the patient’s own biology to deliver life-changing therapeutics to those living with rare diseases. Its proprietary autologous intracellular drug encapsulation (AIDE) technology platform is a drug/device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. The Company’s Phase III lead asset, eDSP, leverages its AIDE technology to encapsulate dexamethasone sodium phosphate (DSP) into a patient’s own red blood cells, and is targeted to treat a rare pediatric neurodegenerative disease, Ataxia-Telangiectasia (A-T). Its AIDE technology is designed to allow for the chronic administration of drugs that have limitations due to toxicity, poor biodistribution, suboptimal pharmacokinetics, or immune response. The AIDE technology platform delivers a variety of therapeutics, ranging from small to large molecules drugs and biologics.

Webull offers Quince Therapeutics Inc stock information, including NASDAQ: QNCX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, QNCX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading QNCX stock methods without spending real money on the virtual paper trading platform.